Everything you care about in one place

Follow feeds: blogs, news, RSS and more. An effortless way to read and digest content of your choice.

Get Feeder

roche.com

Investor Update

Get the latest updates from Investor Update directly as they happen.

Follow now 320 followers

Latest posts

Last updated 1 day ago

Roche presents new data at CTAD, demonstrating its growing momentum in diagnostics for Alzheimer’s disease

1 day ago

New data highlight the potential of the Roche Elecsys® Amyloid Plasma Panel...

Reminder: Invitation to Roche’s Virtual Neurology Investor Event

4 days ago

  We are pleased to invite investors and analysts to participate in our...

Reminder: Invitation to Roche’s 3rd Quarter Sales 2024 Presentation

16 days ago

 Roche will publish its Sales for the 3rd Quarter of 2024 prior...

Majority of children with spinal muscular atrophy (SMA) treated with Roche’s Evrysdi are able to sit, stand and walk independently, two-year data demonstrate

18 days ago

Positive data confirm Evrysdi efficacy and safety in children first treated pre-symptomatically...

Roche submits science-based targets for net zero by 2045

21 days ago

Basel, 11 October 2024 - Roche announced today its submission of greenhouse...

FDA approves Roche’s Itovebi, a targeted treatment for advanced hormone receptor-positive, HER2-negative breast cancer with a PIK3CA mutation

21 days ago

Approval is based on Phase III INAVO120 results, showing the Itovebi™ (inavolisib)-based...

Invitation: Roche’s Virtual Neurology Investor Event

24 days ago

    We are pleased to invite investors and analysts to participate in our...

Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy alone in people with lupus nephritis

about 1 month ago

Positive phase III results for Roche’s Gazyva/Gazyvaro show superiority to standard therapy...

Roche launches the first test to use its breakthrough TAGS technology for high throughput, simultaneous detection of 12 respiratory viruses

about 1 month ago

New TAGS (Temperature-Activated Generation of Signal) technology enables up to 15 targets...

Invitation to Roche’s 3rd Quarter Sales 2024 Presentation

about 1 month ago

  Roche will publish its Sales for the 3rd Quarter of 2024 prior...

Reminder: Invitation to Roche’s Pharma Day 2024

about 1 month ago

    The Roche Investor Relations team would like to invite you to the...